ReviewCurrent neuropharmacology2020

Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.

Alexander N Orekhov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.